|
Relationship between time to trastuzumab initiation and overall survival among young commercially insured women with metastatic breast cancer. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - UnitedHealthcare |
Patents, Royalties, Other Intellectual Property - UpToDate |
|
|
Consulting or Advisory Role - IMS Health |
Travel, Accommodations, Expenses - Novartis |
|
|
No Relationships to Disclose |